Best website builder for ketamine clinics

Why we believe Squarespace is the best website builder for ketamine clinics

Ketamine-assisted therapy patients are not the wellness shoppers some clinic marketers want them to be. Most arrive having already failed two or three medication trials, having read ASKP and the recent APA review, and having watched at least one friend go through a clinic that did it badly. They are reading your site for clinical substance, not lifestyle branding. Scored against that real patient, Squarespace keeps landing where I'd point an independent ketamine clinic first.

Where Wix earns the runner-up spot

Wix earns the runner-up slot for a specific kind of ketamine clinic, not as a second-best-everywhere placement. If the operations manager is already fluent in Wix from a previous practice or the brief is dominated by intake-form logic and multi-location scheduling, Wix is the reasonable call.

Intake logic and branching forms are at the centre of the brief

Wix's native form builder handles conditional logic (branching questions based on prior answers) more forgivingly than Squarespace's default forms. For clinics that want a rich pre-screening questionnaire before the intake call (not a clinical history, which belongs in the EMR, but a qualifying-interest form that segments genuinely treatment-resistant inquiries from the curious-but-unqualified), Wix's form layer is less fiddly. The caveat is that anything collecting PHI still has to leave Wix and move into a HIPAA-covered tool. Wix's own HIPAA posture is partial and changing.

The clinic runs multiple locations and each needs its own sub-site

For a two-or-three-location operation with distinct medical directors at each site, Wix's page-duplication and multi-site-style flexibility saves some setup hours compared to Squarespace. Squarespace handles this fine, but Wix is slightly more forgiving for someone managing parallel location pages with shared-but-not-identical content.

Somebody on the team already knows Wix

The most practical reason. If the clinic's office manager, the founder's spouse, or a part-time marketing coordinator already runs a Wix site elsewhere, the learning-curve saving is real. The editorial gap versus Squarespace templates exists but is bridgeable with careful template selection and aggressive paring-back of stock imagery.

The honest case for Wix stops at the edges. Template tone is the biggest cost. The wellness-labelled templates drift toward marketed-and-hypey out of the box, and it takes real effort to pare them back to a register that reads as clinical. For clinics prioritising the editorial tone that a serious treatment-resistant patient responds to, Squarespace is the tighter starting point. Wix is the reasonable call when in-house familiarity or intake-form complexity outweighs the template-tone gap.

How the other major website builders stack up for ketamine clinics

Scored 1 to 10 on the factors that matter for a typical independent ketamine-assisted therapy clinic (single or two locations, board-certified medical director, mix of IV ketamine and Spravato, in-house or partnered integration therapists, existing EMR in place).

The ketamine-clinic stack: ASKP, FDA framing, psychiatric-board certification, and your own site

A ketamine-assisted therapy clinic sits inside a regulatory and professional ecosystem that's unusually visible to the patient doing research. Getting the ownership model right (what the clinic's website claims, what the professional bodies certify, what the FDA does and doesn't say about ketamine's use) is part of why the site either earns trust or looks like another offshoot of the 2021 psychedelic-startup wave.

ASKP, the American Society of Ketamine Physicians, Psychotherapists and Practitioners (at askp.org), is the professional society whose membership signals a clinician has opted into peer accountability, continuing education, and a standard of practice. A clinic whose medical director is an ASKP member, with the membership named on the provider bio, reads meaningfully differently to a serious patient than one where the credential is absent. This is not a regulatory certification, it's a professional-society membership, and the distinction matters. Name it honestly, link the society, don't inflate it into something it isn't.

FDA regulatory framing is the part most clinic marketers get clumsy about. Racemic IV ketamine is FDA-approved as an anaesthetic. Its use for treatment-resistant depression is off-label and legal, administered under a physician's clinical judgment. Spravato (esketamine nasal spray) is the FDA-approved form specifically for treatment-resistant depression and is dispensed under a REMS program with dedicated observation requirements. A clinic website that states this distinction plainly (IV ketamine off-label, Spravato FDA-approved for TRD under REMS, both clinically legitimate with different logistics and cost profiles) earns trust. A clinic that blurs the line, or that implies FDA approval for IV ketamine's off-label use, reads as either uninformed or dishonest, both disqualifying for the referring psychiatrist and the educated patient.

Psychiatric-board certification and anaesthesiology-board certification are the core credentials to foreground. The medical director of a ketamine clinic is typically board-certified by the American Board of Psychiatry and Neurology (ABPN) or the American Board of Anesthesiology. Stating the board, the year certified, and any relevant subspecialty (addiction psychiatry, pain medicine, consultation-liaison psychiatry) on the provider bio is the first check a careful referring clinician runs. The clinic that makes this easy to verify earns the referral pipeline. The clinic that buries or omits board status loses it silently.

Osmind has emerged as the purpose-built EMR for interventional psychiatry and handles ketamine-specific workflows (dosing documentation, PHQ-9 and GAD-7 tracking, integration-session notes, Spravato REMS compliance) in a way general-purpose EMRs don't. On the smaller end, SimplePractice covers basics with extensions. The marketing website links to the intake but doesn't try to replicate these tools. Posting pre-session questionnaires or collecting medication lists on a Squarespace form is the wrong move every time.

For independent coverage that patients and referring clinicians actually read, the American Psychiatric Association's ketamine clinical guidance and review pieces are the canonical professional reference. Yale's neurobiology-of-depression research program has published foundational work on ketamine for treatment-resistant depression that educated patients will have read. Psychiatric Times covers the clinical and regulatory conversation with nuance a general wellness outlet can't match. Citing these on a protocol or education page, naturally in prose, signals a clinic that operates inside the professional conversation rather than adjacent to it.

What a ketamine clinic actually needs from a website

Seven features do most of the work. The four "must haves" are the difference between a site that converts serious treatment-resistant patients and filters risk, and a site that reads as wellness marketing to everyone who matters. The supervision-plus-protocol page is the single highest-leverage one.

Squarespace handles all seven without extra apps. Wix covers five cleanly, with template-tone work needed on the first three. Shopify fights all seven.

Which Squarespace templates suit ketamine clinics best

Every Squarespace template runs on Fluid Engine and is broadly interchangeable, so the choice is starting aesthetic rather than permanent feature lock-in. These four are the ones I point ketamine-clinic founders toward most often, specifically because they resist the wellness-brochure drift the category is prone to.

Bedford

Classic, clean, editorial. Suits clinics positioning on clinical substance over design flash. Handles protocol pages and screening criteria without forcing the content into marketing-card shapes. Reads trustworthy, which is the single most important register for this category.

Paloma

Photo-first and quieter, with more whitespace around imagery. Works well when the clinic has genuine, consented clinician and facility photography. The risk is that stock imagery of a person holding their forehead by a window reads as dishonest instantly in this category, and Paloma exposes stock more than Bedford does. Use only with real photography.

Brine

Flexible editorial family with strong long-form support. Good for clinics whose medical director plans to publish occasional clinical-education pieces (the difference between IV ketamine and Spravato, integration-therapy framing, aftercare research notes) alongside the core service pages. Reads like a thoughtful practice rather than a service menu.

Marta

Cleaner lines, stronger type hierarchy, holds long written content without forcing it into blog-post shapes. Suits clinics where the medical director is the primary writer and the site's value is the clinical voice rather than imagery.

All four handle the checklist without modification. The template is a starting aesthetic, not a feature set, and the hours spent debating the choice are better spent writing the protocol page and the screening-criteria page. Pick one, launch, revise in month three. For continuing perspective on how patients and referring clinicians actually read ketamine-clinic content, Psychiatric Times covers the clinical register with more nuance than any platform blog, and ASKP's member resources reward operators who want to benchmark their own voice against the society standard.

Common mistakes ketamine clinics make picking a builder

Five patterns show up repeatedly. None are really about the builder. They're about what the clinic lets on its homepage in the first month of launching, before somebody senior reads it and winces.

Leading with a hype-heavy homepage that reads as wellness marketing. The sunset hero, the "rediscover yourself" copy, the testimonial reel before the medical director is even named. Every one of these is borrowed from the 2021 psychedelic-startup wave and every one of them costs the clinic the two patient types that matter: the serious treatment-resistant patient whose psychiatrist warned them to avoid exactly this, and the referring psychiatrist who closes the tab at first sight. Lead with the medical director, the protocol, and the screening process. The wellness imagery can go later or not at all.

No clarity on medical supervision, or implied supervision without naming anyone. A ketamine-clinic homepage that doesn't name the medical director within the first two sections is failing the basic trust test. Who prescribes, who monitors vitals, who manages an adverse event: these are the questions a serious patient has before any other question. The clinic that answers them in plain language on the homepage earns the consult. The clinic that defers them to a "team" page buried three clicks deep loses it.

No integration-therapy framing, as if the sessions themselves are the whole service. Running ketamine dosing without integration therapy is a drip-clinic model, and the serious patient knows the difference. A clinic that doesn't publish what integration looks like, who provides it, what training the integration therapist has, is signalling either that integration isn't actually part of the service or that the clinic doesn't think the frame matters. Both reads cost referrals. The integration page is differentiating in a category where most competitors skip it.

No screening transparency, as if anyone who wants treatment can have it. A clinic that can't articulate who is and isn't a candidate for ketamine-assisted therapy on its website is a risk flag to any psychiatrist reading the page. Publish the screening criteria. Active psychosis, uncontrolled hypertension, specific substance-use patterns, pregnancy, certain medication combinations: these rule patients out, and the clinic willing to say so on-site earns trust the vague-about-eligibility clinic can't touch. Screening transparency also filters your own funnel toward qualified patients who won't waste an intake slot.

No aftercare plan, treating the initial series as the whole arc. The initial six-to-eight-session series is the easy part to market. The harder, differentiating page is what happens after. A clinic with no aftercare framing (booster-session criteria, integration-therapy continuation, handoff back to the outpatient prescriber, monitoring for relapse signals) reads as a clinic that sells a package and moves on. The clinic that publishes a real aftercare plan earns the referring psychiatrist who wants to know their patient won't be left hanging. This is the mistake that costs the slow-compounding referral pipeline, which is the highest-value patient source a clinic has.

Year-round demand, Q1 wellness push, and the months that matter

Ketamine-clinic inquiry volume is closer to flat across the year than most service lines, because treatment-resistant depression doesn't follow a seasonal rhythm the way elective wellness does. That said, Q1 carries a meaningful wellness-push bump (new-year resolutions, fresh HSA and FSA allocations, employer mental-health benefits reset) that compounds with the annual post-holiday dip in mood. The website has to be ready for a steady base with a Q1 spike layered on top.

Protocol and provider-bio pages reviewed each December for the January wave. The January inquiry bump arrives on a site that either reflects current credentials, current integration-therapy partners, and current dosing protocol, or looks stale against the patient cross-checking it against the APA's most recent guidance. Commit to a December review each year. Update board-certification dates, refresh the protocol page if anything in the initial series has changed, and add a short plain-English note on what the clinic has learned in the past twelve months. The clinic that visibly maintains its clinical pages outperforms the set-and-forget one.

Insurance and Spravato-coverage page refreshed at open-enrolment season. November and December send patients back to their HR portals to check mental-health coverage for the next plan year, and Spravato's insurance picture shifts with plan renewals. An updated coverage page in November, with clear language on which Spravato-benefit paths the clinic supports, what out-of-pocket IV ketamine looks like, and how HSA/FSA dollars apply, converts January inquiries that start researching in October. Insurance clarity earns consults that vague pricing pages lose.

Referral-friendly materials ready for the Q1 psychiatrist outreach. January is also when outpatient psychiatrists recalibrate which interventional options they feel comfortable referring to. A clinic with a clean protocol page, named medical director, published screening criteria, and a real aftercare plan has a URL to send. A clinic without those pages is relying on a cold intro and a hope. The website becomes the pre-read for the referral relationship. That compounds over years.

Intake-call capacity matched to Q1 inquiry volume. Website traffic and qualified inquiries both rise in Q1. The clinic that books out its intake slots in the first week of January and makes new inquirers wait three weeks loses the most urgent patients. Review intake-call capacity in mid-December. Raise the cap for January if it's historically constrained. The site earning more consults than the clinic can absorb is worse than the site earning fewer that get answered promptly.

What I'm less sure about. The thing I'm least sure about, and the call on this page most likely to age oddly, is FDA regulatory tightening on off-label ketamine. The off-label use of IV ketamine for treatment-resistant depression currently sits inside standard physician-judgment practice, and the telehealth carve-outs that expanded during the pandemic have already started narrowing. If the FDA, DEA, or state medical boards move to tighten off-label ketamine prescribing further, particularly around at-home and telehealth-dispensed ketamine, the competitive picture shifts quickly. Clinics with a strong in-clinic-supervised IV ketamine practice, full Spravato REMS compliance, and clear medical-director oversight are positioned well for almost any tightening scenario. Clinics leaning on telehealth-only or at-home-ketamine models are exposed. I'd build the site in a way that foregrounds in-clinic supervision and FDA-compliant framing regardless of current scope, because the direction of regulatory travel is clear even if the pace isn't.

Get the clinic site live before the January wave lands

A patient three antidepressants deep has maybe forty seconds on your homepage to decide whether to call. The clinic that names the medical director, shows a written dosing protocol, frames integration therapy as a first-class service, publishes honest screening criteria, and writes a real aftercare plan earns that call. The clinic leading with a sunset hero and "reclaim your life" copy loses it to the ASKP-member clinic down the road. Squarespace's free trial is enough for a motivated medical director or operations lead to publish the essentials (home, provider bios, protocol, screening, integration, Spravato-versus-IV, aftercare, contact) over a focused weekend and refine across the following month. Wix is the reasonable runner-up when in-house familiarity or intake-form complexity is central. Whichever you pick, a live site with honest clinical framing in October outperforms a planned site in February, as the Q1 wave arrives.

Start Squarespace free trial

Or start with Wix if the clinic already has a Wix-savvy person in-house and the intake forms, scheduling, and multi-location logic are the centre of the brief.